Development of a Standardized Scoring System to Assess a Murine Model of Clostridium difficile Colitis
- 20 March 2019
- journal article
- research article
- Published by Taylor & Francis in Journal of Investigative Surgery
- Vol. 33 (10) , 887-895
Abstract
Background: Clostridium difficile infection is the most common cause of antimicrobial-associated diarrhea. Our aim was to introduce a novel and efficient clinical sickness score (CSS), and to define a detailed histologic injury score (HIS) in a murine model of C. difficile colitis. Methods: Mice received an antibiotic cocktail (kanamycin, gentamicin, colistin, metronidazole, and vancomycin) for 96 h. After 48 h, mice received an intraperitoneal injection of clindamycin, followed by oral C. difficile (1.5 × 107 CFU). Signs of sickness were scored using a novel CSS (range 0–12) with scores ≥6 consistent with C. difficile colitis. Intestinal tissue was analyzed utilizing an adapted HIS (range 0–9) with scores ≥4 consistent with C. difficile colitis. Stool was analyzed for C. difficile, and survival evaluated. Results: No control mice showed signs of sickness, whereas 23% of mice receiving antibiotics alone and 65% of mice exposed to antibiotics and subsequently C. difficile demonstrated signs of sickness (p = 0.0134). No control mice had histologic injury, whereas 8% of mice receiving antibiotics alone and 75% of mice exposed to antibiotics followed by C. difficile had evidence of histologic injury (p = 0.0001). Mice exposed to C. difficile lost more weight, although not significant (p = 0.070). Mice that received C. difficile had decreased survival compared to control mice and mice receiving antibiotics only (p = 0.03). Conclusions: We have developed a novel clinical scoring system, and detailed histological grading system, that enables the objective evaluation of a murine C. difficile colitis model. This model allows the study of this disease in a host that demonstrates clinical and histologic signs comparable to human C. difficile infection. This will allow for improved study of therapeutics for this disease in the future.Keywords
This publication has 22 references indexed in Scilit:
- Clostridium difficileInfection: A Worldwide DiseaseGut and Liver, 2014
- Nucleotide-Binding Oligomerization Domain 1 Mediates Recognition of Clostridium difficile and Induces Neutrophil Recruitment and Protection against the PathogenThe Journal of Immunology, 2011
- Clostridium difficile infection: new developments in epidemiology and pathogenesisNature Reviews Microbiology, 2009
- A Mouse Model of Clostridium difficile–Associated DiseaseGastroenterology, 2008
- The development of animal models for the study of necrotizing enterocolitisDisease Models & Mechanisms, 2008
- Pathogenesis and treatment of Clostridium difficile infectionPostgraduate Medical Journal, 2005
- Clostridium difficileToxins: Mechanism of Action and Role in DiseaseClinical Microbiology Reviews, 2005
- Gnotobiotic Models for Study of the Microbial Ecology of Clostridium difficile and Escherichia coliThe Journal of Infectious Diseases, 1986
- Mucosal damage mediated by clostridial toxin in experimental clindamycin-associated colitis.Gut, 1980
- Antibiotic-Associated Colitis: Effects of Antibiotics on Clostridium difficile and the Disease in HamstersClinical Infectious Diseases, 1979